The Tumor-Immune Microenvironment and Response to Radiation Therapy
Open Access
- 16 December 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Mammary Gland Biology and Neoplasia
- Vol. 15 (4), 411-421
- https://doi.org/10.1007/s10911-010-9194-9
Abstract
Chemotherapy and radiation therapy (RT) are standard therapeutic modalities for patients with cancer, including breast cancer. Historic studies examining tissue and cellular responses to RT have predominantly focused on damage caused to proliferating malignant cells leading to their death. However, there is increasing evidence that RT also leads to significant alterations in the tumor microenvironment, particularly with respect to effects on immune cells infiltrating tumors. This review focuses on tumor-associated immune cell responses following RT and discusses how immune responses may be modified to enhance durability and efficacy of RT.Keywords
This publication has 129 references indexed in Scilit:
- Natural Killer Cell Education and ToleranceCell, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasisCytokine & Growth Factor Reviews, 2010
- Lymphocytes in cancer development: Polarization towards pro-tumor immunityCytokine & Growth Factor Reviews, 2010
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- The Many Roles of FAS Receptor Signaling in the Immune SystemImmunity, 2009
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009Cell Death & Differentiation, 2008
- Molecular markers of radiation-related normal tissue toxicityCancer and Metastasis Reviews, 2008
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- The Hallmarks of CancerCell, 2000